The role of peroxisome proliferator-activated receptor γ, and effects of its agonist, rosiglitazone, on transient cerebral ischemic damage

Journal of the Neurological Sciences

Volumn 300, Issue 1-2, 2011, Pages 120-129

  Lee, Choong Hyun ^a   Park, Ok Kyu ^b   Yoo, Ki Yeon ^b   Byun, Kyunghee ^c   Lee, Bonghee ^c   Choi, Jung Hoon ^d   Hwang, In Koo ^a   Kim, Young Myeong ^d   Won, Moo Ho ^d  

^a Seoul National University   (South Korea)

^b Hallym University   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Kangwon National University   (South Korea)

Author keywords

Delayed neuronal death; Gerbil; Hippocampus; Ischemia; Neuroprotection; PPAR ; Rosiglitazone

Indexed keywords

CYTOKINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; GERBIL; GLIA; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; NERVE CELL; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; ASTROCYTES; CA1 REGION, HIPPOCAMPAL; CELL DEATH; DISEASE MODELS, ANIMAL; GERBILLINAE; INTERLEUKIN-13; INTERLEUKIN-4; ISCHEMIC ATTACK, TRANSIENT; MALE; MICROGLIA; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PPAR GAMMA; REPERFUSION; THIAZOLIDINEDIONES;

EID: 78650510608     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.09.005     Document Type: Article

References (54)

1. C.S. Lin, K. Polsky, J.V. Nadler, and B.J. Crain Selective neocortical and thalamic cell death in the gerbil after transient ischemia Neuroscience 35 1990 289 299 (Pubitemid 20176742)
2. A. Rami, T. Volkmann, R. Agarwal, S. Schoninger, F. Nurnberger, T.C. Saido, and J. Winckler beta2-Adrenergic receptor responsiveness of the calpain-calpastatin system and attenuation of neuronal death in rat hippocampus after transient global ischemia Neurosci Res 47 2003 373 382 (Pubitemid 37433829)
3. T. Kirino Delayed neuronal death in the gerbil hippocampus following ischemia Brain Res 239 1982 57 69 (Pubitemid 12101768)
4. R. Schmidt-Kastner, and T.F. Freund Selective vulnerability of the hippocampus in brain ischemia Neuroscience 40 1991 599 636
5. H. Hara, T. Sukamoto, and K. Kogure Mechanism and pathogenesis of ischemia-induced neuronal damage Prog Neurobiol 40 1993 645 670 (Pubitemid 23094669)
6. M.S. Kindy Inhibition of tyrosine phosphorylation prevents delayed neuronal death following cerebral ischemia J Cereb Blood Flow Metab 13 1993 372 377
7. L. Rastogi, M.M. Godbole, M. Ray, P. Rathore, S. Pradhan, S.K. Gupta, and C.M. Pandey Reduction in oxidative stress and cell death explains hypothyroidism induced neuroprotection subsequent to ischemia/reperfusion insult Exp Neurol 200 2006 290 300 (Pubitemid 44107912)
8. M.H. Won, T. Kang, S. Park, G. Jeon, Y. Kim, J.H. Seo, E. Choi, M. Chung, and S.S. Cho The alterations of N-methyl-d-aspartate receptor expressions and oxidative DNA damage in the CA1 area at the early time after ischemia-reperfusion insult Neurosci Lett 301 2001 139 142 (Pubitemid 32206705)
9. J. Vamecq, and N. Latruffe Medical significance of peroxisome proliferator-activated receptors Lancet 354 1999 141 148 (Pubitemid 29313157)
10. J.P. Berger, T.E. Akiyama, and P.T. Meinke PPARs: therapeutic targets for metabolic disease Trends Pharmacol Sci 26 2005 244 251 (Pubitemid 40603072)
11. G. Chinetti, J.C. Fruchart, and B. Staels Peroxisome proliferator- activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation Inflamm Res 49 2000 497 505 (Pubitemid 32294402)
12. B. Verges Clinical interest of PPARs ligands Diabetes Metab 30 2004 7 12
13. A. Bernardo, G. Levi, and L. Minghetti Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions Eur J Neurosci 12 2000 2215 2223 (Pubitemid 30497019)
14. O. Braissant, F. Foufelle, C. Scotto, M. Dauca, and W. Wahli Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat Endocrinology 137 1996 354 366 (Pubitemid 26005011)
15. S. Moreno, S. Farioli-Vecchioli, and M.P. Ceru Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS Neuroscience 123 2004 131 145 (Pubitemid 37518482)
16. Y. Zhu, K. Alvares, Q. Huang, M.S. Rao, and J.K. Reddy Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver J Biol Chem 268 1993 26817 26820 (Pubitemid 24006385)
17. T. Breidert, J. Callebert, M.T. Heneka, G. Landreth, J.M. Launay, and E.C. Hirsch Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease J Neurochem 82 2002 615 624 (Pubitemid 34831499)
18. N.C. Inestrosa, J.A. Godoy, R.A. Quintanilla, C.S. Koenig, and M. Bronfman Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling Exp Cell Res 304 2005 91 104 (Pubitemid 40227422)
19. Y. Luo, W. Yin, A.P. Signore, F. Zhang, Z. Hong, S. Wang, S.H. Graham, and J. Chen Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone J Neurochem 97 2006 435 448
20. S. Sundararajan, J.L. Gamboa, N.A. Victor, E.W. Wanderi, W.D. Lust, and G.E. Landreth Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia Neuroscience 130 2005 685 696 (Pubitemid 39601441)
21. S. Sundararajan, and G.E. Landreth Antiinflammatory properties of PPARgamma agonists following ischemia Drug News Perspect 17 2004 229 236 (Pubitemid 38987364)
22. R.B. Tjalkens, X. Liu, B. Mohl, T. Wright, J.A. Moreno, D.L. Carbone, and S. Safe The peroxisome proliferator-activated receptor-gamma agonist 1, 1-bis(3′-indolyl)-1-(p-trifluoromethylphenyl)methane suppresses manganese-induced production of nitric oxide in astrocytes and inhibits apoptosis in cocultured PC12 cells J Neurosci Res 86 2008 618 629 (Pubitemid 351204475)
23. Y. Zhao, A. Patzer, P. Gohlke, T. Herdegen, and J. Culman The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain Eur J Neurosci 22 2005 278 282 (Pubitemid 41059994)
24. Y. Zhao, A. Patzer, T. Herdegen, P. Gohlke, and J. Culman Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats FASEB J 20 2006 1162 1175 (Pubitemid 44943912)
25. F.J. Antonawich, S.M. Fiore, and L.M. Welicky Regulation of ischemic cell death by the lipoic acid-palladium complex, Poly MVA, in gerbils Exp Neurol 189 2004 10 15
26. D. Chaulk, J. Wells, S. Evans, D. Jackson, and D. Corbett Long-term effects of clomethiazole in a model of global ischemia Exp Neurol 182 2003 476 482 (Pubitemid 36937101)
27. D. Corbett, J. Larsen, and K.D. Langdon Diazepam delays the death of hippocampal CA1 neurons following global ischemia Exp Neurol 214 2008 309 314
28. Y. Zhang, Y. Jin, M.J. Behr, P.J. Feustel, J.P. Morrison, and H.K. Kimelberg Behavioral and histological neuroprotection by tamoxifen after reversible focal cerebral ischemia Exp Neurol 196 2005 41 46 (Pubitemid 41416646)
29. I.K. Hwang, K.Y. Yoo, H. Li, O.K. Park, C.H. Lee, J.H. Choi, Y.G. Jeong, Y.L. Lee, Y.M. Kim, Y.G. Kwon, and M.H. Won Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus J Neurosci Res 87 2009 2126 2137
30. L.C. Schmued, and K.J. Hopkins Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration Brain Res 874 2000 123 130
31. M. Collino, M. Aragno, R. Mastrocola, M. Gallicchio, A.C. Rosa, C. Dianzani, O. Danni, C. Thiemermann, and R. Fantozzi Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion Eur J Pharmacol 530 2006 70 80 (Pubitemid 43037126)
32. R.K. Kaundal, S. Iyer, A. Kumar, and S.S. Sharma Protective effects of pioglitazone against global cerebral ischemic-reperfusion injury in gerbils J Pharmacol Sci 109 2009 361 367
33. T. Shimazu, I. Inoue, N. Araki, Y. Asano, M. Sawada, D. Furuya, H. Nagoya, and J.H. Greenberg A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia Stroke 36 2005 353 359 (Pubitemid 40170822)
34. K. Tureyen, R. Kapadia, K.K. Bowen, I. Satriotomo, J. Liang, D.L. Feinstein, and R. Vemuganti Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents J Neurochem 101 2007 41 56 (Pubitemid 46426485)
35. J. Lee, and M. Reding Effects of thiazolidinediones on stroke recovery: a case-matched controlled study Neurochem Res 32 2007 635 638 (Pubitemid 46481294)
36. P.D. Home, S.J. Pocock, H. Beck-Nielsen, P.S. Curtis, R. Gomis, M. Hanefeld, N.P. Jones, and M. Komajda RECORD Study Team. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial Lancet 373 2009 2125 2135
37. R. Wilcox, M.G. Bousser, D.J. Betteridge, G. Schernthaner, V. Pirags, S. Kupfer, and J. Dormandy PROactive Investigators. Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04) Stroke 38 2007 865 873 (Pubitemid 46568445)
38. Y. Maeshiba, Y. Kiyota, K. Yamashita, Y. Yoshimura, M. Motohashi, and S. Tanayama Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys Arzneimittelforschung 47 1997 29 35 (Pubitemid 27083325)
39. W.A. Pedersen, P.J. McMillan, J.J. Kulstad, J.B. Leverenz, S. Craft, and G.R. Haynatzki Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice Exp Neurol 199 2006 265 273 (Pubitemid 43928978)
40. P.D. Drew, P.D. Storer, J. Xu, and J.A. Chavis Hormone regulation of microglial cell activation: relevance to multiple sclerosis Brain Res Brain Res Rev 48 2005 322 327 (Pubitemid 40585762)
41. T. Kielian, and P.D. Drew Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation J Neurosci Res 71 2003 315 325 (Pubitemid 36159491)
42. C.K. Combs, D.E. Johnson, J.C. Karlo, S.B. Cannady, and G.E. Landreth Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists J Neurosci 20 2000 558 567
43. X. Zhao, G. Sun, J. Zhang, R. Strong, W. Song, N. Gonzales, J.C. Grotta, and J. Aronowski Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages Ann Neurol 61 2007 352 362 (Pubitemid 46676735)
44. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82 (Pubitemid 28079218)
45. I.K. Hwang, K.Y. Yoo, D.W. Kim, S.Y. Choi, T.C. Kang, Y.S. Kim, and M.H. Won Ionized calcium-binding adapter molecule 1 immunoreactive cells change in the gerbil hippocampal CA1 region after ischemia/reperfusion Neurochem Res 31 2006 957 965
46. K.J. Becker Inflammation and acute stroke Curr Opin Neurol 11 1998 45 49
47. G. Stoll, S. Jander, and M. Schroeter Inflammation and glial responses in ischemic brain lesions Prog Neurobiol 56 1998 149 171 (Pubitemid 28432563)
48. Z. Zheng, and M.A. Yenari Post-ischemic inflammation: molecular mechanisms and therapeutic implications Neurol Res 26 2004 884 892 (Pubitemid 39628566)
49. M.T. Heneka, T. Klockgether, and D.L. Feinstein Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo J Neurosci 20 2000 6862 6867
50. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86 (Pubitemid 28079219)
51. A. Ledeboer, J.J. Breve, S. Poole, F.J. Tilders, and A.M. Van Dam Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells Glia 30 2000 134 142 (Pubitemid 30199427)
52. K. Pahan, M. Khan, and I. Singh Interleukin-10 and interleukin-13 inhibit proinflammatory cytokine-induced ceramide production through the activation of phosphatidylinositol 3-kinase J Neurochem 75 2000 576 582 (Pubitemid 30485438)
53. M.S. Yang, E.J. Park, S. Sohn, H.J. Kwon, W.H. Shin, H.K. Pyo, B. Jin, K.S. Choi, I. Jou, and E.H. Joe Interleukin-13 and -4 induce death of activated microglia Glia 38 2002 273 280
54. D.J. Loane, B.F. Deighan, R.M. Clarke, R.J. Griffin, A.M. Lynch, and M.A. Lynch Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain Neurobiol Aging 30 2009 920 931